PureTech Health noted that its Founded Entity, Karuna Therapeutics announced the submission of a new drug application, or NDA, to the FDA for KarXT for the treatment of schizophrenia.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PRTC: